Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy [Phase 1]
A Phase 1 trial evaluating a combination of temozolomide, memantine hydrochloride, mefloquine, and metformin hydrochloride in glioblastoma m…
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Treatment of Recurrent GBM With APG-157 Via Expanded Access
Expanded-access trial of APG-157 for recurrent glioblastoma has been discontinued and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2013-03-28Clinical Trial Update: Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Phase 2]
Phase 2 trial of Carmustine with O6-Benzylguanine for newly diagnosed glioblastoma multiforme has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-03Clinical Trial Update: Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1) [Phase 2]
Phase 2 trial evaluating convection-enhanced localized delivery of PRX321 with real-time imaging for recurrent glioblastoma has been withdra…
-
CLINICAL_TRIALS withdrawal · 2010-01-12Clinical Trial Update: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors [Phase 2]
Phase 2 trial of photodynamic therapy for malignant intracranial tumors has been withdrawn from ClinicalTrials.gov.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2009-01-07Clinical Trial Update: Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme [Phase 3]
Phase 3 trial of TransMID™ for glioblastoma multiforme has been withdrawn.